ARCHIVES

NIH Not Proactive, Healy Tells NCAB ‘Beset’ By Issues

This article is from The Cancer Letter archive.

Vol. 19 No. 07 | February 12, 1993

Download PDF Visit The Full Archive

Related Articles

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

Cancer Advocates Use Benefit Analysis To Press For Funds

May 11, 1990

ASCO proposes compromise to limit payment cuts proposed by Congress, CMS.

September 12, 2003

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

Low Prevalence Of Tamoxifen Use For Cancer Prevention

February 26, 2010

Goodfellow To Lead Gynecologic Oncology Research Team At Ohio State University

January 11, 2013